查找临床试验
已按「年龄相关性黄斑变性」检索，对应国际通用词 age-related macular degeneration
共找到 38 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:26，每 5 分钟自动同步QA108 Phase III Study in Subjects With Intermediate AMD
China
年龄 45 Years – 85 Years
Smilebiotek Zhuhai Limited
Effect of Video Viewing on Intravitreal Injection Experience
China
年龄 18 Years – 不限
Second Affiliated Hospital, Zhejiang University, School of Medicine
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
United States、China
年龄 50 Years – 不限
Skyline Therapeutics
Real-world Study of Aflibercept 8 mg in nAMD
China
年龄 50 Years – 不限
Peking University People's Hospital
Gene Therapy(FT-003) for Wet AMD
China
年龄 50 Years – 80 Years
Frontera Therapeutics
Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics
Taiwan
年龄 20 Years – 不限
National Taiwan University Hospital
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
China
年龄 6 Years – 不限
VeonGen Therapeutics GmbH
Extension Study for the Port Delivery System With Ranibizumab (Portal)
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 50 Years – 不限
Hoffmann-La Roche
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
United States、China、Czechia、Germany、Hungary 等 9 国
年龄 18 Years – 不限
Boehringer Ingelheim
Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
China
年龄 45 Years – 80 Years
Sinocelltech Ltd.
Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD
China
年龄 50 Years – 不限
Beijing Anlong Biopharmaceutical Co., Ltd.
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
China
年龄 50 Years – 85 Years
West China Hospital